The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / A••••••

F•••••••• Announces Sale of A•••••• to L••••• C•••••• P•••••••

Exit to a strategic buyerannouncedannounced Aug 24, 2026Fact
What happened
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
healthcare / behavioral health, pharma
Target location
unknown
Seller kind
Sponsor
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
6 named
Buy side
  • F•••••••• Announces Sale of A•••••• to L••••• C•••••• P•••••••
  • "We would like to thank D•• M•••• and the A•••••• team for their partnership over the last several years," said M•••••• F••••••, Managing Director at F•••••••• F•••.
Sell side
  • F•••••••• F••• ("F••••••••"), a specialist private equity investment firm focused on financial services and adjacent verticals, announced today the successful exit of its investment in A••••••, LLC ("A••••••" or the "Company") to L••••• C•••••• P•••••••.
Advisory side
  • H••••••• L••••Financial adviserconfirmed
    H••••••• L•••• served as financial advisor to the Company.
Side not stated
  • D•• M••••Managementconfirmed
    "We are incredibly proud of the business and culture we have built at A•••••• and the impact our team has on the patients and communities we serve," said D•• M••••, Chief Executive Officer of A••••••.
  • A••••••Targetconfirmed
    F•••••••• Announces Sale of A•••••• to L••••• C•••••• P•••••••
Evidence
F•••••••• Announces Sale of A•••••• to L••••• C•••••• P•••••••
F•••••••• Announces Sale of A•••••• to L••••• C•••••• P••••••• | Private Equity Intelligence | DFX